Ultrasound probe to guide surgery for upper urinary tract cancer
This trial tests whether a special ultrasound probe inserted into the urinary tract can better show how deep the cancer has grown, helping doctors decide on the right surgery. It may improve accuracy in treatment planning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years old or older.
- You have been diagnosed or your doctor strongly suspects you have upper urinary tract cancer based on scans or a biopsy.
- The depth of the cancer is hard to determine with current imaging, and surgery is being considered.
- Your doctor has already chosen to remove the affected kidney and ureter, which allows comparison of the ultrasound findings with the removed tissue.
- Your urinary tract is shaped in a way that allows the small ultrasound probe to reach the cancer safely.
- You are willing to give written consent to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two drugs (toripalimab and 9MW2821) given before surgery for patients with upper tract urothelial cancer that hasn't spread. The goal is to see if this combination can shrink the tumor and improve outcomes.
This Phase 2 trial studies a HER2-targeted medicine (RC48-ADC) plus another drug (JS001) to help prevent cancer from coming back after surgery for upper urinary tract urothelial cancer. It may be an option if your tumor has higher HER2 levels and you have no spread to distant organs.
This trial is testing a system that helps doctors choose the best additional treatment for people with advanced upper tract urothelial cancer (UTUC) after their surgery. It focuses on patients whose cancer has spread into the muscle layer or beyond, or to nearby lymph nodes.
This trial tests a combination of treatments to save the kidney in people with high-risk upper tract urothelial carcinoma. The goal is to remove the cancer while keeping the kidney working, which may be an option if your cancer is at an early stage and your kidney function is good enough.
This trial is for people diagnosed with a rare type of cancer in the upper urinary tract (UTUC). Researchers hope to learn more about this condition and find better ways to treat it.
This trial tests whether giving radiation therapy before surgery can help people with high-risk upper tract urothelial cancer (UTUC). The goal is to improve treatment outcomes for patients who are planning to have their cancer removed.
Hear when a new Upper Tract Urothelial Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.